Immutep (IMMP) Net Margin (2011 - 2017)

Immutep (IMMP) posted Net Margin of 366.03% for Q2 2017, down 183.69% on a QoQ basis from 129.02% in Q1 2017, and up 110239.0% year-over-year from N/an in Q2 2016.

Immutep (IMMP) Net Margin (2011 - 2017) Analysis & Trends

Immutep's Net Margin history runs 5 years deep, the most recent figure standing at 366.03% for Q2 2017.

  • Quarterly Net Margin rose 110239.0% year-over-year to 366.03% in Q2 2017, while the trailing twelve-month figure through Jun 2017 was 408.64% (up 8188.0% YoY) and the FY2025 annual result came in at 1390.28%, down 102751.0% from the prior year.
  • Net Margin was 366.03% for Q2 2017 at Immutep, down from 129.02% in the prior quarter.
  • Across five years, Net Margin topped out at 103.36% in Q2 2014 and bottomed at 1468.42% in Q2 2016.
  • A 4-year average of 505.35% and a median of 425.29% in 2015 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2016 — Net Margin tumbled 98386 bps — and 2017, when it jumped 110239 bps.
  • Immutep's Net Margin stood at 103.36% in 2014, then slumped by 569 bps to 484.56% in 2015, then slumped by 203 bps to 1468.42% in 2016, then jumped by 75 bps to 366.03% in 2017.
  • Business Quant data shows IMMP's Net Margin at 366.03% in Q2 2017, 129.02% in Q1 2017, and 1468.42% in Q2 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 15.02%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 20.17%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 28.20%
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Immutep 569.08 Mn 569.08 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2017 -366.03%
Mar 31, 2017 -129.02%
Jun 30, 2016 -1,468.42%
Mar 31, 2016 -687.45%
Jun 30, 2015 -484.56%
Jun 30, 2014 103.36%
Jun 30, 2011 100.31%